Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.89 USD | +3.18% | +5.42% | -7.60% |
Sales 2024 * | 55.9M 60.62M | Sales 2025 * | 86.34M 93.64M | Capitalization | 803M 871M |
---|---|---|---|---|---|
Net income 2024 * | -211M -229M | Net income 2025 * | -130M -141M | EV / Sales 2024 * | 12.3 x |
Net cash position 2024 * | 117M 127M | Net cash position 2025 * | 26.5M 28.74M | EV / Sales 2025 * | 9 x |
P/E ratio 2024 * |
-3.74
x | P/E ratio 2025 * |
-6.69
x | Employees | 1,086 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.73% |
Latest transcript on CureVac N.V.
1 day | +3.18% | ||
1 week | +5.42% | ||
1 month | +54.37% | ||
3 months | +13.74% | ||
6 months | -27.96% | ||
Current year | -7.60% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 23-03-27 | |
Pierre Kemula
DFI | Director of Finance/CFO | 50 | 16-10-31 |
Malte Greune
COO | Chief Operating Officer | 59 | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Tooman
BRD | Director/Board Member | 58 | 19-05-31 |
Michael Brosnan
BRD | Director/Board Member | 69 | 23-06-18 |
Director/Board Member | 67 | 22-06-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.74% | 17 M€ | -.--% | - | |
0.06% | 2 M€ | -.--% | ||
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 3.89 | +3.18% | 1,105,122 |
24-05-30 | 3.77 | -0.53% | 860,410 |
24-05-29 | 3.79 | +3.27% | 2,260,556 |
24-05-28 | 3.67 | -0.54% | 2,211,323 |
24-05-24 | 3.69 | -7.05% | 1,783,519 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.60% | 871M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- CVAC Stock